Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions

Jiyoung Lee1, Jinho Lee, Kevin S Farquhar

  • 1Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637.

Insights

Cancer metastasis can be influenced by non-genetic factors. This study reveals a feedback loop between BACH1 and RKIP, impacting breast cancer progression and variability.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Systems Biology

Background:

  • Nongenetic variability significantly influences metastatic progression, but its sources remain largely unknown.
  • Raf kinase inhibitory protein (RKIP) is a known metastasis suppressor.
  • The transcription factor BACH1 promotes breast cancer metastasis and is negatively regulated by RKIP.

Purpose of the Study:

  • To characterize the transcriptional regulatory network of RKIP.
  • To elucidate the role of BACH1 in regulating RKIP and its impact on metastatic progression.
  • To investigate the mechanisms underlying nongenetic variability in cancer metastasis.

Main Methods:

  • Transcriptional regulatory network analysis of RKIP and BACH1.
  • Investigation of feedback loops involving BACH1 and RKIP.
  • Single-cell analysis to confirm network dynamics.
  • Experimental manipulation using histone deacetylase inhibitors and polycomb repressor depletion.

Main Results:

  • BACH1 forms a double-negative feedback loop inhibiting RKIP transcription in breast cancer cells.
  • BACH1 also negatively autoregulates its own transcription.
  • An inverse relationship between BACH1 and RKIP, exhibiting monostable and bistable transitions, was identified, contributing to nongenetic variability.
  • Single-cell analyses confirmed monostable and bistable-like behaviors.
  • Modulation of histone deacetylase inhibitors or enhancer of zeste homolog 2 led to a prometastatic state.

Conclusions:

  • The mutually repressive relationship between RKIP and BACH1 is a key driver of nongenetic variability and metastatic progression in cancer.
  • Understanding these regulatory networks offers potential therapeutic targets for controlling cancer metastasis.
  • Nongenetic mechanisms play a critical role in the complex process of cancer metastasis.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K